Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome (Q84020869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

W Krone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M Hanefeld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

H-F Meyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

T Jung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M Bartlett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

C-M Yeh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

I Rajman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M F Prescott

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

W P Dole

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

8 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

186-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20376075%20AND%20SRC:MED&resulttype=core&format=json

Prognostic value of the metabolic syndrome in essential hypertension

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Metabolic syndrome and target organ damage in untreated essential hypertensives.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Metabolic syndrome and cardiovascular risk in primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Co-expression of renin-angiotensin system genes in human adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Blood pressure control in patients with comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Aliskiren: a review of its use in the management of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Renin inhibition with aliskiren: where are we now, and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Conformational changes in prorenin during renin inhibition in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021

Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.38

7 January 2021